IncyteCARES: Helping Eligible
Patients With Access and Support

We’re Here to Support Your Eligible Patients During Treatment

Our mission is to help your patients start and stay on therapy by assisting with access and as-needed support.

Enroll Your Eligible Patients in IncyteCARES

Completing the enrollment form takes about 15 minutes.

Select a Medication

• JAKAFI® (ruxolitinib)/
  JAKAFI XR™ (ruxolitinib)
• MONJUVI® (tafasitamab-cxix)
• Niktimvo™ (axatilimab-csfr)
• OPZELURA® (ruxolitinib) cream
• PEMAZYRE® (pemigatinib)
• ZYNYZ® (retifanlimab-dlwr)

Patients with
commercial insurance

IncyteCARES
Savings Program

Eligible patients with commercial health insurance can receive medication for as little as $0–$15, subject to certain limits.

Select a Medication

• JAKAFI® (ruxolitinib)/
  JAKAFI XR™ (ruxolitinib)
• MONJUVI®
  (tafasitamab-cxix)
• Niktimvo™
  (axatilimab-csfr)
• OPZELURA® (ruxolitinib) cream
• PEMAZYRE® (pemigatinib)
• ZYNYZ®
  (retifanlimab-dlwr)

Patients who are uninsured
or underinsured

IncyteCARES
Patient Assistance
Program

Eligible patients can receive medicine free of charge.

Select a Medication

• JAKAFI® (ruxolitinib)/
  JAKAFI XR™ (ruxolitinib)
• MONJUVI®
  (tafasitamab-cxix)
• Niktimvo™
  (axatilimab-csfr)
• OPZELURA® (ruxolitinib) cream
• PEMAZYRE® (pemigatinib)
• ZYNYZ®
  (retifanlimab-dlwr)

ICD-10-CM
Codes

Find quick-reference billing codes.

Select a Medication

• JAKAFI® (ruxolitinib)/
  JAKAFI XR™ (ruxolitinib)
• MONJUVI®
  (tafasitamab-cxix)
• Niktimvo™
  (axatilimab-csfr)
• OPZELURA® (ruxolitinib) cream
• PEMAZYRE® (pemigatinib)
• ZYNYZ®
  (retifanlimab-dlwr)

Forms, Documents,
and More

Access helpful practice resources like ready-to-use letter templates and forms.

Select a Medication

• JAKAFI® (ruxolitinib)/
  JAKAFI XR™ (ruxolitinib)
• MONJUVI®
  (tafasitamab-cxix)
• Niktimvo™
  (axatilimab-csfr)
• OPZELURA® (ruxolitinib) cream
• PEMAZYRE® (pemigatinib)
• ZYNYZ®
  (retifanlimab-dlwr)

All Support Options
Available for Your Patients

Select a medication to find out what savings and additional resources may be available for your patients.

Select a Medication

• JAKAFI® (ruxolitinib)/
  JAKAFI XR™ (ruxolitinib)
• MONJUVI®
  (tafasitamab-cxix)
• Niktimvo™
  (axatilimab-csfr)
• OPZELURA® (ruxolitinib) cream
• PEMAZYRE® (pemigatinib)
• ZYNYZ®
  (retifanlimab-dlwr)

Quick Downloads

• Letter of Medical Necessity
• Medical Exception
• Letter of Appeal

Questions?

Call IncyteCARES at 1-855-452-5234

Monday through Friday, 8 AM–8 PM ET